Title: Ethical Implications of Pharmaceutical Company Influence on Behavior Analysis Research

Thesis Statement:

In the given scenario, Jiang, a BCBA, faces a potential ethical dilemma influenced by the pharmaceutical company’s expectations and financial support. The discussion will focus on the implications of Code 5.07 from the Ethics Code for Behavior Analysts, highlighting the importance of maintaining objectivity and integrity in research practices.

Rationale for Chosen Code(s):

– Code 5.07: This code emphasizes the obligation of behavior analysts to conduct research and provide services with scientific and professional rigor, free from undue influence. It underscores the importance of maintaining objectivity and integrity in all professional activities.

Code Violation:

Jiang may be at risk of violating Code 5.07 if she allows the pharmaceutical company’s financial support and expectations to influence the design, implementation, or reporting of her research study. This could compromise the integrity and objectivity of the research findings.

Antecedent Factors Contributing to Scenario:

1. Financial dependence on the pharmaceutical company for research funding.
2. Pressure from the pharmaceutical company to align research outcomes with their commercial interests.
3. Lack of clear boundaries or guidelines regarding industry influence on research practices.

Preventative Strategies:

1. Establish clear research agreements that ensure independence in study design and data analysis.
2. Seek consultation from ethics committees or experienced researchers on managing conflicts of interest.
3. Maintain transparency in disclosing any financial or organizational ties that could impact the research outcomes.

Ethical Course of Action:

Jiang should uphold her professional integrity by ensuring that the research study is conducted independently and without bias towards the pharmaceutical company’s interests. She should establish clear boundaries with the company, maintain transparency in her research practices, and prioritize the scientific validity and ethical considerations of the study.

Future Risk Factors to Keep in Mind:

1. Potential bias in research findings favoring the pharmaceutical company’s interests.
2. Damage to professional reputation and credibility due to perceived conflicts of interest.
3. Ethical and legal implications if research misconduct or undue influence is discovered during or after the study.

In conclusion, maintaining ethical standards in behavior analysis research is crucial for upholding the integrity and credibility of the field. Jiang must navigate the complex dynamics of industry influence with caution, ensuring that her research remains independent, objective, and aligned with scientific principles. By prioritizing ethical considerations and transparency in her research practices, Jiang can mitigate potential risks and uphold the professional standards expected of behavior analysts.